PEG-MGF

PEG-MGF is a pegylated mechano-growth-factor analog studied for longer-lasting satellite-cell and tissue-repair signaling than native MGF, with the evidence base remaining preclinical.

Profile · 01

Overview

PEG-MGF is a pegylated variant of mechano growth factor, an IGF-1 splice isoform associated with tissue damage and repair signaling. The source frames pegylation as a way to extend half-life and make the biology more durable than native MGF.

Like MGF itself, PEG-MGF remains a preclinical entry. The source applies a once-daily subcutaneous titration structure even though no human clinical trials define a standard therapeutic protocol.

At a Glance

Goal
Support muscle-repair, satellite-cell activation, and tissue-regeneration research with a longer-lasting MGF analog
Categories
Muscle GrowthRecoveryTissue RepairRegeneration
Synergistic
IGF-1 LR3 · CJC-1295 NO DAC · Ipamorelin · BPC-157 · TB-500
Profile · 02

Protocol

Suggested once-daily titration approach increasing every two weeks toward the upper target range.

Reconstitute
Add 3.0 mL bacteriostatic water to a 2 mg vial for about 0.667 mg/mL concentration
Typical daily range
200-500 mcg once daily
Start
200 mcg daily for Weeks 1-2
Target
400-500 mcg daily by Weeks 5-8
Frequency
Once daily (subcutaneous)
Cycle Length
8 weeks with optional extension to 12 weeks
Timing
Post-workout or any consistent time; rotate injection sites
Route
Subcutaneous
Cycle
8 weeks on, 4 weeks off

Inject once daily subcutaneously using a relatively dilute reconstitution that keeps the dose readable. The source positions PEG-MGF as the longer-lasting relative of native MGF, but practical dosing remains built on preclinical logic rather than human trial evidence.

Dose progression

Weeks 1-2
200 mcg (0.20 mg) · 30 units (0.30 mL)
Weeks 3-4
300 mcg (0.30 mg) · 45 units (0.45 mL)
Weeks 5-6
400 mcg (0.40 mg) · 60 units (0.60 mL)
Weeks 7-8
500 mcg (0.50 mg) · 75 units (0.75 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How PEG-MGF works.

PEG-MGF is intended to retain the tissue-repair signaling associated with the MGF E-peptide while extending half-life through PEGylation. The source frames it as a longer-duration satellite-cell and regenerative-signal compound than native MGF.

Preclinical work discusses myogenic precursor proliferation plus broader muscle, bone, and cartilage repair observations. No human clinical trials establish safety, efficacy, or an evidence-based dosing framework for the protocol summarized here.

Science · 02

Effects

Observations from clinical or preclinical literature.

Preclinical work suggests support for muscle-repair and satellite-cell activity
PEGylation may provide a longer duration than native MGF
May be discussed in research stacks aimed at recovery from heavy training or tissue stress
Human efficacy and safety data are absent
Mild injection-site irritation may occur
Long-term systemic effects remain unknown
Science · 03

Caution

Avoid in active cancer or significant cancer history because growth-factor signaling can be growth-promoting
Not recommended during pregnancy or breastfeeding because safety data is absent
Use caution when combining with other IGF-1 or GH-axis compounds
This remains a preclinical research peptide rather than a validated medical therapy

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Protein intake
Provides substrate for muscle-repair and growth signaling.
Creatine
Supports training output and recovery alongside regenerative goals.
Zinc
Supports wound healing and cellular repair processes.
Magnesium
Supports muscle function and enzymatic recovery pathways.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Use progressive resistance training if the goal is muscle-adaptation signaling
Maintain adequate protein intake and overall recovery capacity
Prioritize sleep because repair-focused peptides cannot replace sleep-driven adaptation
Balance stimulus and recovery rather than stacking heavy training onto poor recovery habits
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Muscle soreness and recovery time - useful for tracking training-recovery changes
  2. Strength and performance - monitor progressive overload or functional output
  3. Body composition - follow lean-mass and recovery-related trends
  4. Injection-site reactions - note redness, swelling, or discomfort
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

IGF-1
Provides growth-factor-pathway context during use.
CBC (Complete Blood Count)
General baseline and follow-up monitoring.
CMP (Comprehensive Metabolic Panel)
Assesses liver and kidney function during the protocol.
Fasting glucose and HbA1c
Useful metabolic markers because IGF-pathway signaling intersects with glucose biology.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 2 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Rotate sites across the abdomen, thighs, and upper arms to reduce local irritation
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely
PEG-MGF and native MGF should not be treated as interchangeable despite shared lineage
Document dose, site rotation, and training context for consistency
All practical dosing here is based on preclinical extrapolation rather than human clinical trials
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. Molecular Endocrinology
    Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast biology.
    https://pubmed.ncbi.nlm.nih.gov/12065764/
  2. Journal of Cell Science
    IGF splicing and satellite-cell activation following muscle damage.
    https://pubmed.ncbi.nlm.nih.gov/12665563/
  3. FASEB Journal
    Mechano growth factor splice variant review in muscle maintenance and aging.
    https://pubmed.ncbi.nlm.nih.gov/15485750/
  4. Growth Hormone and IGF Research
    Discussion of PEGylation improving MGF stability and activity.
    https://pubmed.ncbi.nlm.nih.gov/18706850/
  5. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
On this page